nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—Central nervous system disorder—Glyburide—gestational diabetes	0.0381	0.136	CcSEcCtD
Alitretinoin—Vitamin A—RBP4—gestational diabetes	0.0345	1	CrCbGaD
Alitretinoin—Allergic cutaneous angiitis—Glyburide—gestational diabetes	0.024	0.0861	CcSEcCtD
Alitretinoin—CRABP2—Vitamin A and Carotenoid Metabolism—RBP4—gestational diabetes	0.0225	0.052	CbGpPWpGaD
Alitretinoin—CRABP1—Vitamin A and Carotenoid Metabolism—RBP4—gestational diabetes	0.0225	0.052	CbGpPWpGaD
Alitretinoin—CRABP1—embryo—gestational diabetes	0.0221	0.0867	CbGeAlD
Alitretinoin—CRABP2—embryo—gestational diabetes	0.02	0.0784	CbGeAlD
Alitretinoin—RXRB—islet of Langerhans—gestational diabetes	0.017	0.0667	CbGeAlD
Alitretinoin—Leukocytoclastic vasculitis—Glyburide—gestational diabetes	0.0156	0.0559	CcSEcCtD
Alitretinoin—RARG—Vitamin A and Carotenoid Metabolism—RBP4—gestational diabetes	0.0152	0.0351	CbGpPWpGaD
Alitretinoin—RXRG—Vitamin A and Carotenoid Metabolism—RBP4—gestational diabetes	0.0139	0.0321	CbGpPWpGaD
Alitretinoin—Blindness—Glyburide—gestational diabetes	0.0138	0.0495	CcSEcCtD
Alitretinoin—RARB—Vitamin A and Carotenoid Metabolism—RBP4—gestational diabetes	0.0136	0.0315	CbGpPWpGaD
Alitretinoin—CRABP2—adipose tissue—gestational diabetes	0.0132	0.0517	CbGeAlD
Alitretinoin—RXRB—Vitamin A and Carotenoid Metabolism—RBP4—gestational diabetes	0.0131	0.0302	CbGpPWpGaD
Alitretinoin—RARA—Vitamin A and Carotenoid Metabolism—RBP4—gestational diabetes	0.0131	0.0302	CbGpPWpGaD
Alitretinoin—CRABP1—vagina—gestational diabetes	0.0121	0.0475	CbGeAlD
Alitretinoin—Encephalopathy—Glyburide—gestational diabetes	0.0119	0.0427	CcSEcCtD
Alitretinoin—RXRG—adipose tissue—gestational diabetes	0.0115	0.0452	CbGeAlD
Alitretinoin—CRABP1—head—gestational diabetes	0.0112	0.0439	CbGeAlD
Alitretinoin—CRABP2—vagina—gestational diabetes	0.0109	0.043	CbGeAlD
Alitretinoin—RXRG—Adipogenesis—RETN—gestational diabetes	0.0107	0.0248	CbGpPWpGaD
Alitretinoin—RARG—Nuclear Receptors—AR—gestational diabetes	0.0106	0.0246	CbGpPWpGaD
Alitretinoin—CRABP2—head—gestational diabetes	0.0101	0.0397	CbGeAlD
Alitretinoin—RARA—Adipogenesis—RETN—gestational diabetes	0.0101	0.0233	CbGpPWpGaD
Alitretinoin—RXRA—head—gestational diabetes	0.0101	0.0395	CbGeAlD
Alitretinoin—RARG—uterus—gestational diabetes	0.00982	0.0386	CbGeAlD
Alitretinoin—Coagulopathy—Glyburide—gestational diabetes	0.00981	0.0352	CcSEcCtD
Alitretinoin—RARB—vagina—gestational diabetes	0.00978	0.0385	CbGeAlD
Alitretinoin—RXRG—Nuclear Receptors—AR—gestational diabetes	0.00972	0.0225	CbGpPWpGaD
Alitretinoin—RARG—adipose tissue—gestational diabetes	0.0096	0.0377	CbGeAlD
Alitretinoin—RARB—Nuclear Receptors—AR—gestational diabetes	0.00953	0.0221	CbGpPWpGaD
Alitretinoin—RARA—uterus—gestational diabetes	0.00923	0.0363	CbGeAlD
Alitretinoin—RARA—Nuclear Receptors—AR—gestational diabetes	0.00914	0.0211	CbGpPWpGaD
Alitretinoin—RXRB—Nuclear Receptors—AR—gestational diabetes	0.00914	0.0211	CbGpPWpGaD
Alitretinoin—RARB—head—gestational diabetes	0.00904	0.0355	CbGeAlD
Alitretinoin—RARA—adipose tissue—gestational diabetes	0.00903	0.0355	CbGeAlD
Alitretinoin—RXRB—vagina—gestational diabetes	0.00899	0.0353	CbGeAlD
Alitretinoin—RXRG—head—gestational diabetes	0.00883	0.0347	CbGeAlD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—ADIPOQ—gestational diabetes	0.00854	0.0198	CbGpPWpGaD
Alitretinoin—RARG—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.0084	0.0194	CbGpPWpGaD
Alitretinoin—RXRB—head—gestational diabetes	0.00831	0.0326	CbGeAlD
Alitretinoin—RARG—vagina—gestational diabetes	0.00798	0.0314	CbGeAlD
Alitretinoin—Vasculitis—Glyburide—gestational diabetes	0.00783	0.0281	CcSEcCtD
Alitretinoin—RXRG—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.00768	0.0178	CbGpPWpGaD
Alitretinoin—RARB—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.00753	0.0174	CbGpPWpGaD
Alitretinoin—RXRG—Regulation of Androgen receptor activity—AR—gestational diabetes	0.00745	0.0172	CbGpPWpGaD
Alitretinoin—RARG—head—gestational diabetes	0.00737	0.029	CbGeAlD
Alitretinoin—RXRA—Endogenous sterols—CYP19A1—gestational diabetes	0.00732	0.0169	CbGpPWpGaD
Alitretinoin—RXRB—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.00722	0.0167	CbGpPWpGaD
Alitretinoin—RARA—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.00722	0.0167	CbGpPWpGaD
Alitretinoin—RXRB—Regulation of Androgen receptor activity—AR—gestational diabetes	0.007	0.0162	CbGpPWpGaD
Alitretinoin—RARA—head—gestational diabetes	0.00693	0.0272	CbGeAlD
Alitretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—gestational diabetes	0.00688	0.0159	CbGpPWpGaD
Alitretinoin—RXRA—Vitamin A and Carotenoid Metabolism—RBP4—gestational diabetes	0.00681	0.0157	CbGpPWpGaD
Alitretinoin—Deafness—Glyburide—gestational diabetes	0.0062	0.0222	CcSEcCtD
Alitretinoin—Renal failure acute—Glyburide—gestational diabetes	0.006	0.0215	CcSEcCtD
Alitretinoin—Visual disturbance—Glyburide—gestational diabetes	0.00585	0.021	CcSEcCtD
Alitretinoin—Renal impairment—Glyburide—gestational diabetes	0.00583	0.0209	CcSEcCtD
Alitretinoin—Dermatitis bullous—Glyburide—gestational diabetes	0.0058	0.0208	CcSEcCtD
Alitretinoin—Arthritis—Glyburide—gestational diabetes	0.0057	0.0205	CcSEcCtD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—LEP—gestational diabetes	0.0053	0.0123	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—RETN—gestational diabetes	0.00526	0.0122	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—NAMPT—gestational diabetes	0.00514	0.0119	CbGpPWpGaD
Alitretinoin—RXRA—Circadian Clock—NAMPT—gestational diabetes	0.00501	0.0116	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—NAMPT—gestational diabetes	0.00483	0.0112	CbGpPWpGaD
Alitretinoin—Abdominal distension—Glyburide—gestational diabetes	0.00482	0.0173	CcSEcCtD
Alitretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—gestational diabetes	0.00479	0.0111	CbGpPWpGaD
Alitretinoin—RXRA—Nuclear Receptors—AR—gestational diabetes	0.00476	0.011	CbGpPWpGaD
Alitretinoin—Pancreatitis—Glyburide—gestational diabetes	0.0047	0.0168	CcSEcCtD
Alitretinoin—Sweating increased—Glyburide—gestational diabetes	0.00467	0.0167	CcSEcCtD
Alitretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—gestational diabetes	0.00438	0.0101	CbGpPWpGaD
Alitretinoin—Photosensitivity reaction—Glyburide—gestational diabetes	0.00437	0.0157	CcSEcCtD
Alitretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—gestational diabetes	0.0043	0.00994	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—ADIPOQ—gestational diabetes	0.00421	0.00973	CbGpPWpGaD
Alitretinoin—RXRA—Biological oxidations—GGCT—gestational diabetes	0.0042	0.00973	CbGpPWpGaD
Alitretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—gestational diabetes	0.00412	0.00953	CbGpPWpGaD
Alitretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—gestational diabetes	0.00412	0.00953	CbGpPWpGaD
Alitretinoin—Agranulocytosis—Glyburide—gestational diabetes	0.00399	0.0143	CcSEcCtD
Alitretinoin—RARA—Adipogenesis—ADIPOQ—gestational diabetes	0.00396	0.00915	CbGpPWpGaD
Alitretinoin—Hepatitis—Glyburide—gestational diabetes	0.00384	0.0138	CcSEcCtD
Alitretinoin—RXRA—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.00376	0.00871	CbGpPWpGaD
Alitretinoin—Visual impairment—Glyburide—gestational diabetes	0.0037	0.0133	CcSEcCtD
Alitretinoin—RXRA—Regulation of Androgen receptor activity—AR—gestational diabetes	0.00365	0.00844	CbGpPWpGaD
Alitretinoin—Eye disorder—Glyburide—gestational diabetes	0.00358	0.0129	CcSEcCtD
Alitretinoin—RXRA—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.0034	0.00786	CbGpPWpGaD
Alitretinoin—Alopecia—Glyburide—gestational diabetes	0.00339	0.0122	CcSEcCtD
Alitretinoin—Erythema—Glyburide—gestational diabetes	0.00334	0.012	CcSEcCtD
Alitretinoin—Malnutrition—Glyburide—gestational diabetes	0.00334	0.012	CcSEcCtD
Alitretinoin—Vision blurred—Glyburide—gestational diabetes	0.00315	0.0113	CcSEcCtD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—gestational diabetes	0.00313	0.00725	CbGpPWpGaD
Alitretinoin—Tremor—Glyburide—gestational diabetes	0.00313	0.0112	CcSEcCtD
Alitretinoin—Anaemia—Glyburide—gestational diabetes	0.00309	0.0111	CcSEcCtD
Alitretinoin—Convulsion—Glyburide—gestational diabetes	0.00289	0.0104	CcSEcCtD
Alitretinoin—Myalgia—Glyburide—gestational diabetes	0.00284	0.0102	CcSEcCtD
Alitretinoin—Arthralgia—Glyburide—gestational diabetes	0.00284	0.0102	CcSEcCtD
Alitretinoin—RXRA—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.00275	0.00637	CbGpPWpGaD
Alitretinoin—Confusional state—Glyburide—gestational diabetes	0.00275	0.00985	CcSEcCtD
Alitretinoin—Oedema—Glyburide—gestational diabetes	0.00272	0.00977	CcSEcCtD
Alitretinoin—ABCB1—islet of Langerhans—gestational diabetes	0.00269	0.0106	CbGeAlD
Alitretinoin—Shock—Glyburide—gestational diabetes	0.00268	0.00962	CcSEcCtD
Alitretinoin—Nervous system disorder—Glyburide—gestational diabetes	0.00267	0.00958	CcSEcCtD
Alitretinoin—Thrombocytopenia—Glyburide—gestational diabetes	0.00267	0.00957	CcSEcCtD
Alitretinoin—Hyperhidrosis—Glyburide—gestational diabetes	0.00263	0.00945	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.00262	0.00606	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—LEP—gestational diabetes	0.00261	0.00605	CbGpPWpGaD
Alitretinoin—ABCB1—embryo—gestational diabetes	0.0026	0.0102	CbGeAlD
Alitretinoin—Anorexia—Glyburide—gestational diabetes	0.0026	0.00932	CcSEcCtD
Alitretinoin—Hypotension—Glyburide—gestational diabetes	0.00255	0.00913	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—NAMPT—gestational diabetes	0.00252	0.00583	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.00251	0.00581	CbGpPWpGaD
Alitretinoin—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.00248	0.0089	CcSEcCtD
Alitretinoin—RARA—Adipogenesis—LEP—gestational diabetes	0.00246	0.00568	CbGpPWpGaD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—TNF—gestational diabetes	0.00245	0.00568	CbGpPWpGaD
Alitretinoin—Paraesthesia—Glyburide—gestational diabetes	0.00245	0.00878	CcSEcCtD
Alitretinoin—Dyspnoea—Glyburide—gestational diabetes	0.00243	0.00871	CcSEcCtD
Alitretinoin—Dyspepsia—Glyburide—gestational diabetes	0.0024	0.0086	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—GGCT—gestational diabetes	0.00238	0.00549	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GGCT—gestational diabetes	0.00238	0.00549	CbGpPWpGaD
Alitretinoin—Decreased appetite—Glyburide—gestational diabetes	0.00237	0.0085	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Glyburide—gestational diabetes	0.00235	0.00844	CcSEcCtD
Alitretinoin—CYP1A2—Phase II conjugation—GGCT—gestational diabetes	0.00229	0.0053	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Glyburide—gestational diabetes	0.00225	0.00805	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Glyburide—gestational diabetes	0.00223	0.00799	CcSEcCtD
Alitretinoin—Urticaria—Glyburide—gestational diabetes	0.00216	0.00776	CcSEcCtD
Alitretinoin—Abdominal pain—Glyburide—gestational diabetes	0.00215	0.00773	CcSEcCtD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—gestational diabetes	0.00215	0.00497	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GLS2—gestational diabetes	0.00208	0.0048	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GLS2—gestational diabetes	0.00208	0.0048	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—ADIPOQ—gestational diabetes	0.00206	0.00477	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Glyburide—gestational diabetes	0.00201	0.0072	CcSEcCtD
Alitretinoin—Asthenia—Glyburide—gestational diabetes	0.00196	0.00701	CcSEcCtD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—LEP—gestational diabetes	0.00195	0.0045	CbGpPWpGaD
Alitretinoin—Pruritus—Glyburide—gestational diabetes	0.00193	0.00691	CcSEcCtD
Alitretinoin—Diarrhoea—Glyburide—gestational diabetes	0.00186	0.00669	CcSEcCtD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.00186	0.00429	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.00186	0.00429	CbGpPWpGaD
Alitretinoin—ABCB1—uterus—gestational diabetes	0.00175	0.00689	CbGeAlD
Alitretinoin—Vomiting—Glyburide—gestational diabetes	0.00173	0.00621	CcSEcCtD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.00172	0.00398	CbGpPWpGaD
Alitretinoin—Rash—Glyburide—gestational diabetes	0.00172	0.00616	CcSEcCtD
Alitretinoin—Dermatitis—Glyburide—gestational diabetes	0.00172	0.00616	CcSEcCtD
Alitretinoin—ABCB1—adipose tissue—gestational diabetes	0.00171	0.00674	CbGeAlD
Alitretinoin—Headache—Glyburide—gestational diabetes	0.00171	0.00612	CcSEcCtD
Alitretinoin—Nausea—Glyburide—gestational diabetes	0.00162	0.00581	CcSEcCtD
Alitretinoin—RXRA—Biological oxidations—CYP19A1—gestational diabetes	0.00146	0.00338	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—AR—gestational diabetes	0.00145	0.00336	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.00143	0.00331	CbGpPWpGaD
Alitretinoin—ABCB1—vagina—gestational diabetes	0.00143	0.0056	CbGeAlD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.00137	0.00317	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—GGCT—gestational diabetes	0.00134	0.0031	CbGpPWpGaD
Alitretinoin—CYP1A2—Tryptophan metabolism—CYP19A1—gestational diabetes	0.00134	0.0031	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—AR—gestational diabetes	0.00133	0.00307	CbGpPWpGaD
Alitretinoin—ABCB1—head—gestational diabetes	0.00132	0.00517	CbGeAlD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.00131	0.00303	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—AR—gestational diabetes	0.0013	0.00301	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—LEP—gestational diabetes	0.00128	0.00296	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—AR—gestational diabetes	0.00125	0.00289	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—AR—gestational diabetes	0.00125	0.00289	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—TNF—gestational diabetes	0.00121	0.0028	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—NAMPT—gestational diabetes	0.00114	0.00263	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—NAMPT—gestational diabetes	0.00114	0.00263	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—TNF—gestational diabetes	0.00114	0.00263	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GCK—gestational diabetes	0.00113	0.00262	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GCK—gestational diabetes	0.00113	0.00262	CbGpPWpGaD
Alitretinoin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00108	0.00251	CbGpPWpGaD
Alitretinoin—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.00107	0.00247	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—gestational diabetes	0.000901	0.00208	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.00088	0.00204	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000879	0.00203	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000871	0.00202	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—GCK—gestational diabetes	0.00086	0.00199	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000835	0.00193	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CYP19A1—gestational diabetes	0.000827	0.00191	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CYP19A1—gestational diabetes	0.000827	0.00191	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000731	0.00169	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GGCT—gestational diabetes	0.000719	0.00166	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000715	0.00165	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—ADIPOQ—gestational diabetes	0.000709	0.00164	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—AR—gestational diabetes	0.000698	0.00162	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—AR—gestational diabetes	0.00065	0.0015	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—AR—gestational diabetes	0.000639	0.00148	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GLS2—gestational diabetes	0.000629	0.00145	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—AR—gestational diabetes	0.000626	0.00145	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—AR—gestational diabetes	0.000601	0.00139	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—AR—gestational diabetes	0.000601	0.00139	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—TNF—gestational diabetes	0.000592	0.00137	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000562	0.0013	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000523	0.00121	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—CYP19A1—gestational diabetes	0.000467	0.00108	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00046	0.00106	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—LEP—gestational diabetes	0.00044	0.00102	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000435	0.00101	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000434	0.001	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000434	0.001	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TNF—gestational diabetes	0.000353	0.000816	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NAMPT—gestational diabetes	0.000344	0.000797	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GCK—gestational diabetes	0.000342	0.000792	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—FGF2—gestational diabetes	0.000334	0.000773	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—AR—gestational diabetes	0.000313	0.000724	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000292	0.000675	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GGCT—gestational diabetes	0.000287	0.000665	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000286	0.000661	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GLS2—gestational diabetes	0.000251	0.000581	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP19A1—gestational diabetes	0.00025	0.000579	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GGCT—gestational diabetes	0.000229	0.000531	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—gestational diabetes	0.000204	0.000471	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GLS2—gestational diabetes	0.000201	0.000464	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000179	0.000415	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000174	0.000403	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NAMPT—gestational diabetes	0.000138	0.000318	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GCK—gestational diabetes	0.000137	0.000316	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NAMPT—gestational diabetes	0.00011	0.000254	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GCK—gestational diabetes	0.000109	0.000253	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP19A1—gestational diabetes	0.0001	0.000231	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP19A1—gestational diabetes	7.98e-05	0.000185	CbGpPWpGaD
